Mesoblast, Telix Pharmaceuticals and Lindian Resources remain in focus as clinical progress, healthcare innovation and rare earth development shape growth narratives.
Could Mesoblast (ASX:MSB), Telix (ASX:TLX) and Lindian (ASX:LIN) Stay in Growth Focus?
